Oncogenic EP300 can be targeted with inhibitors of aldo-keto reductases
Autor: | Mahmud, Zimam, Asaduzzaman, Muhammad, Kumar, Uttom, Masrour, Nahal, Jugov, Roman, Coombes, R. Charles, Shousha, Sami, Hu, Yunhui, Lam, Eric W.-F., Yagüe, Ernesto |
---|---|
Zdroj: | In Biochemical Pharmacology May 2019 163:391-403 |
Databáze: | ScienceDirect |
Externí odkaz: |